Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Filings indexed 783 across all filing types
Latest filing 2026-05-12 Major Shareholding Noti…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Major shareholder disclosure in Medistim ASA - Attachment: 2026-05-12_Medistim_major_shareholder_disclosure.pdf
Major Shareholding Notification Classification · 95% confidence The document is an ESMA ‘Standard form for notification of major holdings’ where SEB Funds AB reports its voting rights crossing a threshold on Medistim ASA shares. It is clearly a notification of changes in significant share ownership levels as required by the Major Shareholding Notification rules (Directive 2004/109/EC). There is no financial performance data, management commentary, or proxy solicitation—this is purely a threshold disclosure. Therefore, it should be classified as Major Shareholding Notification (MRQ).
2026-05-12 English
Major shareholder disclosure in Medistim ASA
Major Shareholding Notification Classification · 92% confidence The document title and text clearly indicate a major shareholder disclosure, i.e., notification of changes in significant share ownership levels. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-05-12 English
Ex dividend NOK 8.00 today
Regulatory Filings
2026-05-07 Norwegian
First quarter financial results 2026 for Medistim ASA - Attachment: Q1 2026 PPT presentation FINAL.pdf
Regulatory Filings
2026-05-07 Norwegian
First quarter financial results 2026 for Medistim ASA - Attachment: Q1 2026 Financial Report-FINAL.pdf
Regulatory Filings
2026-05-07 Norwegian
First quarter financial results 2026 for Medistim ASA
Regulatory Filings
2026-05-07 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.